Table 1 |
|||||
|
Profile of cardiovascular medications, smoking and psychosocial status at baseline and one year post-admission |
|||||
|
Baseline |
One year |
OR |
95% CI |
p-value |
|
|
|
|||||
|
Cardiovascular Medications |
|||||
|
Aspirin |
88% |
87% |
1.2 |
0.8–1.8 |
0.334 |
|
Antihypertensive≪/Blood Pressure |
94% |
72% |
6.8 |
4.5–10.7 |
<0.001*** |
|
Statins/Cholesterol |
83% |
84% |
0.9 |
0.6–1.2 |
0.437 |
|
Smoking status |
|||||
|
Current Smoker |
40% |
22% |
18.9 |
9.3–44.5 |
<0.001*** |
|
Median number of cigarettes smoked per day (IQR) |
20 (18–30) |
10 (7–20) |
- |
- |
<0.001*** |
|
Psychosocial status |
|||||
|
Full/part-time employment§ |
64% |
54% |
2.7 |
1.6–4.6 |
<0.001*** |
|
Depression≪≪ |
15% |
17% |
0.8 |
0.5–1.3 |
0.434 |
|
HADS-D |
14% |
19% |
0.7 |
0.4–1.2 |
0.169 |
|
BDI-FS |
16% |
15% |
1.3 |
0.5–2.9 |
0.701 |
|
|
|||||
|
(*p < .05, **p < .01, ***p < .001) ≪ – includes angiotensin converting enzyme inhibitors, betablockers, calcium antagonists and diuretics § – For those patients <65 years on index admission (n = 363) ≪≪ – For those who completed a depression scale at baseline and follow-up (n = 447) |
|||||
|
McGee et al. BMC Health Services Research 2006 6:9 doi:10.1186/1472-6963-6-9 |
|||||